No abstract available
Keywords:
atopic dermatitis; bimekizumab; biologics; brodalumab; hidradenitis suppurativa (HS)/acne inversa therapy; psoriasis; supplement.
Grants and funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.